Ophthalmic drug delivery systems for the treatment of retinal diseases: basic research to clinical applications.
作者信息
Edelhauser Henry F, Rowe-Rendleman Cheryl L, Robinson Michael R, Dawson Daniel G, Chader Gerald J, Grossniklaus Hans E, Rittenhouse Kay D, Wilson Clive G, Weber David A, Kuppermann Baruch D, Csaky Karl G, Olsen Timothy W, Kompella Uday B, Holers V Michael, Hageman Gregory S, Gilger Brian C, Campochiaro Peter A, Whitcup Scott M, Wong Wai T
机构信息
Department of Ophthalmology, Emory University, Atlanta, Georgia 30322, USA.
出版信息
Invest Ophthalmol Vis Sci. 2010 Nov;51(11):5403-20. doi: 10.1167/iovs.10-5392.
Abstract
摘要
相似文献
1
Ophthalmic drug delivery systems for the treatment of retinal diseases: basic research to clinical applications.用于治疗视网膜疾病的眼科药物递送系统：从基础研究到临床应用
Invest Ophthalmol Vis Sci. 2010 Nov;51(11):5403-20. doi: 10.1167/iovs.10-5392.
2
[Ocular pharmacology in the treatment of vitreous, retina and choroid diseases].[眼部药理学在玻璃体、视网膜及脉络膜疾病治疗中的应用]
Arq Bras Oftalmol. 2010 May-Jun;73(3):294-9. doi: 10.1590/s0004-27492010000300018.
3
Intravitreal drug delivery in retinal disease: are we out of our depth?视网膜疾病的玻璃体内药物递送：我们是否力不从心？
Expert Opin Drug Deliv. 2014 Oct;11(10):1575-90. doi: 10.1517/17425247.2014.927864. Epub 2014 Jun 14.
4
Drug delivery to posterior intraocular tissues: third Annual ARVO/Pfizer Ophthalmics Research Institute Conference.药物递送至眼内后部组织：第三届ARVO/辉瑞眼科研究所年度会议
Invest Ophthalmol Vis Sci. 2008 Nov;49(11):4712-20. doi: 10.1167/iovs.08-1904. Epub 2008 Aug 15.
5
An update on the latest strategies in retinal drug delivery.视网膜药物递释最新策略的更新。
Expert Opin Drug Deliv. 2024 May;21(5):695-712. doi: 10.1080/17425247.2024.2358886. Epub 2024 May 27.
6
Challenges and opportunities for drug delivery to the posterior of the eye.眼部后段递药的挑战与机遇。
Drug Discov Today. 2019 Aug;24(8):1679-1684. doi: 10.1016/j.drudis.2019.05.035. Epub 2019 Jun 5.
7
Nanostructure-based platforms-current prospective in ophthalmic drug delivery.基于纳米结构的平台——眼科药物递送的当前前景。
Indian J Ophthalmol. 2014 Jul;62(7):768-72. doi: 10.4103/0301-4738.138301.
8
Efficient bottle adaptation provides for adjustment of ophthalmic drop volume and drug dosage.高效的瓶体适配可实现眼药水滴注量和药物剂量的调整。
Clin Exp Ophthalmol. 2014 Sep-Oct;42(7):704-5. doi: 10.1111/ceo.12312. Epub 2014 Apr 8.
9
Pharmaceutical Emulsions: A Viable Approach for Ocular Drug Delivery.药用乳剂：一种可行的眼部给药途径。
J Ocul Pharmacol Ther. 2024 Jun;40(5):261-280. doi: 10.1089/jop.2023.0166. Epub 2024 Apr 23.
10
Pharmaceutical Formulation Methods for Improving Retinal Drug Delivery.改善视网膜药物递送的药物制剂方法。
Semin Ophthalmol. 2019;34(4):218-222. doi: 10.1080/08820538.2019.1620799. Epub 2019 May 30.
引用本文的文献
1
Preparation and Characterization of Triamcinolone Acetonide-Loaded Lipid Liquid Crystal Nanocarriers for Ocular Delivery.用于眼部给药的曲安奈德脂质液晶纳米载体的制备与表征
Adv Pharm Bull. 2024 Dec 5;15(1):70-81. doi: 10.34172/apb.43671. eCollection 2025 Apr.
2
Advancements in Ocular Modelling and Simulations: Key Considerations and Case Studies.眼部建模与模拟的进展：关键考量因素及案例研究
AAPS PharmSciTech. 2024 Dec 17;26(1):14. doi: 10.1208/s12249-024-03001-7.
3
Polydopamine-Based Targeted Nanosystem for Chemo/Photothermal Therapy of Retinoblastoma in a Mouse Orthotopic Model.基于聚多巴胺的靶向纳米系统用于小鼠原位模型中视网膜母细胞瘤的化疗/光热治疗。
Int J Nanomedicine. 2024 Jul 30;19:7799-7816. doi: 10.2147/IJN.S467949. eCollection 2024.
4
Extracellular vesicle encapsulated nicotinamide delivered via a trans-scleral route provides retinal ganglion cell neuroprotection.经巩膜途径递送的细胞外囊泡包裹烟酰胺可提供视网膜神经节细胞保护。
Acta Neuropathol Commun. 2024 Apr 22;12(1):65. doi: 10.1186/s40478-024-01777-0.
5
An Update on Strategies to Deliver Protein and Peptide Drugs to the Eye.向眼部递送蛋白质和肽类药物的策略更新
ACS Omega. 2023 Sep 22;8(39):35470-35498. doi: 10.1021/acsomega.3c02897. eCollection 2023 Oct 3.
6
Discovery and Potential Utility of a Novel Non-Invasive Ocular Delivery Platform.一种新型非侵入性眼部给药平台的发现及潜在应用
Pharmaceutics. 2023 Sep 19;15(9):2344. doi: 10.3390/pharmaceutics15092344.
7
Active Transport and Ocular Distribution of Intravitreally Injected Liposomes.主动转运与玻璃体内注射脂质体的眼内分布。
Transl Vis Sci Technol. 2023 Aug 1;12(8):20. doi: 10.1167/tvst.12.8.20.
8
Innovative Strategies for Drug Delivery to the Ocular Posterior Segment.药物递送至眼后段的创新策略。
Pharmaceutics. 2023 Jul 1;15(7):1862. doi: 10.3390/pharmaceutics15071862.
9
Nanocarriers for ocular drug delivery: Recent advances and future opportunities.用于眼部药物递送的纳米载体：最新进展与未来机遇。
Indian J Ophthalmol. 2023 Jun;71(6):2355-2366. doi: 10.4103/ijo.IJO_1893_22.
10
Ocular Delivery of Therapeutic Proteins: A Review.治疗性蛋白质的眼部给药：综述
Pharmaceutics. 2023 Jan 6;15(1):205. doi: 10.3390/pharmaceutics15010205.
本文引用的文献
1
An experimental platform for systemic drug delivery to the retina.一种用于向视网膜进行全身药物递送的实验平台。
Proc Natl Acad Sci U S A. 2009 Oct 20;106(42):17817-22. doi: 10.1073/pnas.0908561106. Epub 2009 Oct 12.
2
Delivery of PAR-4 plasmid in vivo via nanoliposomes sensitizes colon tumor cells subcutaneously implanted into nude mice to 5-FU.通过纳米脂质体体内递送 PAR-4 质粒使皮下植入裸鼠的结肠肿瘤细胞对 5-FU 敏感。
Cancer Biol Ther. 2009 Oct;8(19):1831-7. doi: 10.4161/cbt.8.19.9592.
3
Effects of ciliary muscle plasmid electrotransfer of TNF-alpha soluble receptor variants in experimental uveitis.睫状肌质粒电转移 TNF-α可溶性受体变体对实验性葡萄膜炎的影响。
Gene Ther. 2009 Jul;16(7):862-73. doi: 10.1038/gt.2009.43. Epub 2009 May 14.
4
Nanoliposomal short-chain ceramide inhibits agonist-dependent translocation of neurotensin receptor 1 to structured membrane microdomains in breast cancer cells.纳米脂质体短链神经酰胺抑制乳腺癌细胞中神经降压素受体1依赖激动剂向结构化膜微区的转位。
Mol Cancer Res. 2009 May;7(5):724-34. doi: 10.1158/1541-7786.MCR-08-0322. Epub 2009 May 12.
5
Oxidative stress renders retinal pigment epithelial cells susceptible to complement-mediated injury.氧化应激使视网膜色素上皮细胞易受补体介导的损伤。
J Biol Chem. 2009 Jun 19;284(25):16939-16947. doi: 10.1074/jbc.M808166200. Epub 2009 Apr 21.
6
Calcium phosphate nanocomposite particles for in vitro imaging and encapsulated chemotherapeutic drug delivery to cancer cells.用于体外成像及将封装的化疗药物递送至癌细胞的磷酸钙纳米复合颗粒。
Nano Lett. 2008 Dec;8(12):4116-21. doi: 10.1021/nl802098g.
7
Encapsulation of organic molecules in calcium phosphate nanocomposite particles for intracellular imaging and drug delivery.用于细胞内成像和药物递送的有机分子在磷酸钙纳米复合颗粒中的封装。
Nano Lett. 2008 Dec;8(12):4108-15. doi: 10.1021/nl8019888.
8
Novel drug delivery systems for retinal diseases. A review.用于视网膜疾病的新型药物递送系统。综述。
Ophthalmic Res. 2009;41(3):124-35. doi: 10.1159/000209665. Epub 2009 Mar 26.
9
A targeted inhibitor of the alternative complement pathway reduces angiogenesis in a mouse model of age-related macular degeneration.一种替代补体途径的靶向抑制剂可减少年龄相关性黄斑变性小鼠模型中的血管生成。
Invest Ophthalmol Vis Sci. 2009 Jul;50(7):3056-64. doi: 10.1167/iovs.08-2222. Epub 2009 Mar 5.
10
Near-infrared emitting fluorophore-doped calcium phosphate nanoparticles for in vivo imaging of human breast cancer.用于人类乳腺癌体内成像的近红外发光荧光团掺杂磷酸钙纳米颗粒。
ACS Nano. 2008 Oct 28;2(10):2075-84. doi: 10.1021/nn800448r.
Zotero 插件